Search

Immunotherapy, in particular immune checkpoint blockade (ICB) therapy targeting the programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) axis, has remarkably revolutionized cancer treatment in the clinic. Anti-PD-1/PD-L1 therapy is designed to restore the antitumor response of cytotoxic T cells (CTLs) by blocking the interaction between PD-L1 on tumour cells and PD-1 on CTLs. Nevertheless, current anti-PD-1/PD-L1 therapy suffers from poor therapeutic outcomes in a large variety of solid tumours due to insufficient tumour specificity, severe cytotoxic effects, and the occurrence of immune resistance. In recent years, nanosized drug delivery systems (NDDSs), endowed with highly efficient tumour targeting and versatility for combination therapy, have paved a new avenue for cancer immunotherapy. In this review article, we summarized the recent advances in NDDSs for anti-PD-1/PD-L1 therapy. We then discussed the challenges and further provided perspectives to promote the clinical application of NDDS-based anti-PD-1/PD-L1 therapy.

The introduction of unintended oil spills into the marine ecosystem has a significant impact on aquatic life and raises important environmental concerns. The present review summarizes the recent studies where nanocomposites are applied to treat oil spills. The review deals with the techniques used to fabricate nanocomposites and identify the characteristics of nanocomposites beneficial for efficient recovery and treatment of oil spills. It classifies the nanocomposites into four categories, namely bio-based materials, polymeric materials, inorganic-inorganic nanocomposites, and carbon-based nanocomposites, and provides an insight into understanding the interactions of these nanocomposites with different types of oils. Among nanocomposites, bio-based nanocomposites are the most cost-effective and environmentally friendly. The grafting or modification of magnetic nanoparticles with polymers or other organic materials is preferred to avoid oxidation in wet conditions. The method of synthesizing magnetic nanocomposites and functionalization polymer is essential as it influences saturation magnetization. Notably, the inorganic polymer-based nanocomposite is very less developed and studied for oil spill treatment. Also, the review covers some practical considerations for treating oil spills with nanocomposites. Finally, some aspects of future developments are discussed. The terms "Environmentally friendly," "cost-effective," and "low cost" are often used, but most of the studies lack a critical analysis of the cost and environmental damage caused by chemical alteration techniques. However, the oil and gas industry will considerably benefit from the stimulation of ideas and scientific discoveries in this field.

Funding Information: The authors thank Jari Leskinen and Virpi Miettinen at SIB Labs of the University of Eastern Finland for technical support in TEM imaging. This work was supported by the Academy of Finland (projects 314412), and the Ganjiang New Area: Program for High‐Level Talents Introduction. Publisher Copyright: © 2022 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH. Transmission electron microscopy (TEM) observations of negatively stained cell membrane (CM)-coated polymeric nanoparticles (NPs) reveal a characteristic core-shell structure. However, negative staining agents can create artifacts that complicate the determination of the actual NP structure. Herein, it is demonstrated with various bare polymeric core NPs, such as poly(lactic-co-glycolic acid) (PLGA), poly(ethylene glycol) methyl ether-block-PLGA, and poly(caprolactone), that certain observed core-shell structures are actually artifacts caused by the staining process. To address this issue, fluorescence quenching was applied to quantify the proportion of fully coated NPs and statistical TEM analysis was used to identify and differentiate whether the observed core-shell structures of CM-coated PLGA (CM−PLGA) NPs are due to artifacts or to the CM coating. Integrated shells in TEM images of negatively stained CM−PLGA NPs are identified as artifacts. The present results challenge current understanding of the structure of CM-coated polymeric NPs and encourage researchers to use the proposed characterization approach to avoid misinterpretations.

Photothermal therapy (PTT) in combination with other treatment modalities has shown great potential to activate immunotherapy against tumor metastasis. However, the nanoparticles (NPs) that generate PTT have served as the photothermal agent only. Moreover, researchers have widely utilized highly immunogenic tumor models to evaluate the immune response of these NPs thus giving over-optimistic results. In the present study black porous silicon (BPSi) NPs were developed to serve as both the photothermal agent and the adjuvant for PTT-based antitumor immunotherapy. We found that the poorly immunogenic tumor models such as B16 are more valid to evaluate NP-based immunotherapy than the widely used immunogenic models such as CT26. Based on the B16 cancer model, a cocktail regimen was developed that combined BPSi-based PTT with doxorubicin (DOX) and cytosine-phosphate-guanosine (CpG). BPSi-based PTT was an important trigger to activate the specific immunotherapy to inhibit tumor growth by featuring the selective upregulation of TNF-α. Either by adding a low dose DOX or by prolonging the laser heating time, a similar efficacy of immunotherapy was evoked to inhibit tumor growth. Moreover, BPSi acted as a co-adjuvant for CpG to significantly boost the immunotherapy. The present study demonstrates that the BPSi-based regimen is a potent and safe antitumor immunotherapy modality. Moreover, our study highlighted that tuning the laser heating parameters of PTT is an alternative to the toxic cytostatic to evoke immunotherapy, paving the way to optimize the PTT-based combination therapy for enhanced efficacy and decreased side effects. STATEMENT OF SIGNIFICANCE: Tumor metastasis causes directly or indirectly more than 90% of cancer deaths. Combination of photothermal therapy (PTT), chemotherapy and immunotherapy based on nanoparticles (NPs) has shown great potential to inhibit distant and metastatic tumors. However, these NPs typically act only as photothermal agents and many of them have been evaluated with immunogenic tumor models. The present study developed black porous silicon working as both the photothermal conversion agent and the immunoadjuvant to inhibit distant tumor. It was recognized that the poorly immunogenic tumor model B16 is more appropriate to evaluate immunotherapy than the widely used immunogenic model CT26. The coordination mechanism of the PTT-based combination therapy regimen was discovered in detail, paving the way to optimize cancer immunotherapy for enhanced efficacy and decreased side effects.

Black porous silicon nanoparticles (BPSi NPs) are known as highly efficient infrared light absorbers that are well-suitable for photothermal therapy (PTT) and photoacoustic imaging (PAI). PTT and PAI require a sufficient number of effectively light-absorbing NPs to be accumulated in tumor after intravenous administration. Herein, biodistribution of PEGylated BPSi NPs with different sizes (i.e., 140, 200, and 300 nm in diameter) is investigated after intravenous administration in mice. BPSi NPs were conjugated with fluorescent dyes Cy5.5 and Cy7.5 to track them in vitro and in vivo, respectively. Optical imaging with an in vivo imaging system (IVIS) was found to be an inadequate technique to assess the biodistribution of the dye-labeled BPSi NPs in vivo because the intrinsic strong absorbance of the BPSi NPs interfered fluorescence detection. This challenge was resolved via the use of inductively coupled plasma optical emission spectrometry to analyze ex vivo the silicon content in different tissues and tumors. The results indicated that most of the polyethylene glycol-coated BPSi NPs were found to accumulate in the liver and spleen after intravenous injection. The smallest 140 nm particles accumulated the most in tumors at an amount of 9.5 ± 3.4% of the injected dose (concentration of 0.18 ± 0.08 mg/mL), the amount known to produce sufficient heat for cancer PTT. Furthermore, the findings from the present study also suggest that techniques other than optical imaging should be considered to study the organ biodistribution of NPs with strong light absorbance properties.

Strict regulations are in place to control the effluents of mining sites and other industries. Heavy metal contamination of aquatic systems caused by leakages is difficult to mitigate as it takes time to detect and localize the leak. Dynamic sampling would drastically reduce the time to locate leakages and allow faster actions to reduce the impact on the environment. The present study introduces a novel portable multielement water analysis system to simultaneously measure Mn, Ni, Cu, Zn, Pb, and U in water samples from natural sources within 15 min from the sampling. The metals are preconcentrated from a 10 mL water sample into a nanoporous filter based on bisphosphonate-modified thermally carbonized porous silicon. The metals can be conveniently analyzed from the filter with a portable XRF analyzer in field conditions. The system was empirically calibrated for a lake water matrix with neutral pH and low alkaline metal concentration. A strong correlation between the XRF intensities and the ICP-MS results was obtained in a concentration range from 50 to 10 000 μg/L. With a DPO-2000C XRF analyzer, the detection limits were 103, 86, 92, 35, 44, and 43 μg/L for Mn, Ni, Cu, Zn, Pb, and U, respectively. The corresponding values with X-MET8000 Expert Geo were 137, 46, 62, 38, 29, and 54. The system was successfully validated with simulated multielement lake water samples and piloted in field conditions. The system provides an efficient way to monitor metals in environmental waters in cases where quick on-site results are needed.

Functional colloidal nanoparticles capable of converting between various energy types are finding an increasing number of applications. One of the relevant examples concerns light-to-heat-converting colloidal nanoparticles that may be useful for localized photothermal therapy of cancers. Unfortunately, quantitative comparison and ranking of nanoheaters are not straightforward as materials of different compositions and structures have different photophysical and chemical properties and may interact differently with the biological environment. In terms of photophysical properties, the most relevant information to rank these nanoheaters is the light-to-heat conversion efficiency, which, along with information on the absorption capacity of the material, can be used to directly compare materials. In this work, we evaluate the light-to-heat conversion properties of 17 different nanoheaters belonging to different groups (plasmonic, semiconductor, lanthanide-doped nanocrystals, carbon nanocrystals, and metal oxides). We conclude that the light-to-heat conversion efficiency alone is not meaningful enough as many materials have similar conversion efficiencies─in the range of 80-99%─while they significantly differ in their extinction coefficient. We therefore constructed their qualitative ranking based on the external conversion efficiency, which takes into account the conventionally defined light-to-heat conversion efficiency and its absorption capacity. This ranking demonstrated the differences between the samples more meaningfully. Among the studied systems, the top-ranking materials were black porous silicon and CuS nanocrystals. These results allow us to select the most favorable materials for photo-based theranostics and set a new standard in the characterization of nanoheaters.

Obesity is one of the major global threats to human health and risk factors for cardiometabolic diseases and certain cancers. Glucagon-like peptide-1 (GLP-1) plays a major role in appetite and glucose homeostasis and recently the USFDA approved GLP-1 agonists for the treatment of obesity and type 2 diabetes. GLP-1 is secreted from enteroendocrine L-cells in the distal part of the gastrointestinal (GI) tract in response to nutrient ingestion. Endogenously released GLP-1 has a very short half-life oflt;2 min and most of the nutrients are absorbed before reaching the distal GI tract and colon, which hinders the use of nutritional compounds for appetite regulation. The review article focuses on nutrients that endogenously stimulate GLP-1 and peptide YY (PYY) secretion via their receptors in order to decrease appetite as preventive action. In addition, various delivery technologies such as pH-sensitive, mucoadhesive, time-dependent, and enzyme-sensitive systems for colonic targeting of nutrients delivery are described. Sustained colonic delivery of nutritional compounds could be one of the most promising approaches to prevent obesity and associated metabolic diseases by, e.g., sustained GLP-1 release.

The recently discovered low-load metal-assisted catalytic etching (LL-MACE) creates nanostructured Si with controllable and variable characteristics that distinguish this technique from the conventional high-load variant. LL-MACE employs 150 times less metal catalyst and produces porous Si instead of Si nanowires. In this work, we demonstrate that some of the features of LL-MACE cannot be explained by the present understanding of MACE. With mechanistic insight derived from extensive experimentation, it is demonstrated that (1) the method allows the use of not only Ag, Pd, Pt, and Au as metal catalysts but also Cu and (2) judicious combinations of process parameters such as the type of metal, Si doping levels, and etching temperatures facilitate control over yield (0.065-88%), pore size (3-100 nm), specific surface area (20-310 m2·g-1), and specific pore volume (0.05-1.05 cm3·g-1). The porous structure of the product depends on the space-charge layer, which is controlled by the Si doping and the chemical identity of the deposited metal. The porous structure was also dependent on the dynamic structure of the deposited metal. A distinctive comet-like structure of metal nanoparticles was observed after etching with Cu, Ag, Pd, and, in some cases, Pt; this structure consisted of 10-50 nm main particles surrounded by smaller (

Mesoporous silicon (PSi) nanoparticles have been widely studied in different biomedical imaging modalities due to their several beneficial material properties. However, they have not been found to be suitable for photoacoustic imaging due to their poor photothermal conversion performance. In the present study, biodegradable black mesoporous silicon (BPSi) nanoparticles with strong light absorbance were developed as superior image contrast agents for photoacoustic tomography (PAT), which was realized with a light-emitting diode (LED) instead of the commonly used laser. LED-based PAT offers the advantages of low cost, compactness, good mobility, and easy operation as compared to the traditional laser-based PAT modality. Nevertheless, the poor imaging sensitivity of the LED-PAT systems has been the main barrier to prevent their wide biomedical application because the LED light has low optical energy. The present study demonstrated that the imaging sensitivity of the LED-PAT system was significantly enhanced with the PEGylated BPSi (PEG-BPSi) nanoparticles. The PEG-BPSi nanoparticles were clearly detectable with a low concentration of 0.05 mg/mL in vitro and with an LED radiation energy of 5.2 μJ. The required concentration of the PEG-BPSi nanoparticles was 10 times lesser than that of the reference gold nanoparticles to reach the corresponding level of the imaging contrast. The ex vivo studies demonstrated that the submillimeter BPSi nanoparticle-based absorbers were distinguishable in chicken breast tissues. The strong contrast provided by the BPSi particles indicated that these particles can be utilized as novel contrast agents in PAT, especially in LED-based systems with low light intensity.

Mesoporous silicon (PSi) is an emerging nanomaterial studied in e.g. biomedical, sensor and energy applications. In many applications, a major obstacle in its commercial use is the instability of its surfaces, especially when functionalized with organic molecules. In the present work, we introduce a surface functionalization method for PSi, in which carbonized surface of silicon is functionalized with terminal alkenes. A good surface coverage of 0.3 molecules per nm2 was achieved and the material showed excellent aqueous stability at low and neutral pH. It also withstood a highly basic solution for several days. The developed method was used to graft bisphosphonates on the surface and the material was used for metal adsorption. Because of its excellent stability, the adsorbent material lasted up to 50 adsorption/desorption cycles without a significant deterioration of its performance.

Nuclear medicine imaging plays an important role in nanomedicine. However, it is still challenging to develop a versatile platform to make the nonviral nanovectors used in cancer therapy biotraceable. In the present study, a robust approach to radiolabel inorganic nanovectors for SPECT and PET imaging was developed. The approach was based on the bisphosphonates (BP) conjugated on the nanovector, mesoporous silicon (PSi) nanoparticles. BP served as an efficient chelator for various radionuclides. For both of the

The number of in vitro, ex vivo, and in vivo studies on porous silicon (PSi) nanoparticles for biomedical applications has increased extensively over the last decade. The focus of the reports has been on the carrier properties of PSi concerning the therapeutic aspect due to several beneficial nanovector characteristics including high payload capacity, biocompatibility, and versatile surface chemistry. Recently, increasing attention has been paid to the diagnostic aspects of PSi, which is typically attributed to the biotraceability of the nanovector. Also, PSi has been studied as a contrast agent. When both these aspects, therapy and diagnosis, are integrated into one nanovector, we can discuss a real nanotheranostics approach. Herein, we review the recent progress developing PSi for various imaging modalities, specifically focusing on optical imaging, magnetic resonance imaging, and nuclear medicine imaging. Furthermore, we summarized the knowledge gaps that must be covered before applying PSi in clinical imaging, highlighting future research trends.

Nutrients stimulate the secretion of glucagon-like peptide-1 (GLP-1), an incretin hormone, secreted from enteroendocrine L-cells which decreases food intake. Thus, GLP-1 analogs are approved for the treatment of obesity, yet cost and side effects limit their use. L-cells are mainly localized in the distal ileum and colon, which hinders the utilization of nutrients targeting GLP-1 secretion. This study proposes a controlled delivery system for nutrients, inducing a prolonged endogenous GLP-1 release which results in a decrease food intake.α-Linolenic acid (αLA) was loaded into thermally hydrocarbonized porous silicon (THCPSi) particles. In vitro characterization and in vivo effects of αLA loaded particles on GLP-1 secretion and food intake were studied in mice. A total of 40.4 ± 3.2% of loaded αLA is released from particles into biorelevant buffer over 24 h, and αLA loaded THCPSi significantly increased in vitro GLP-1 secretion. Single-dose orally given αLA loaded mesoporous particles increased plasma active GLP-1 levels at 3 and 4 h and significantly reduced the area under the curve of 24 h food intake in mice.αLA loaded THCPSi particles could be used to endogenously stimulate sustain gastrointestinal hormone release and reduce food intake.

Embargo 12 kk The inability of traditional chemotherapeutics to reach cancer tissue reduces the treatment efficacy and leads to adverse effects. A multifunctional nanovector was developed consisting of porous silicon, superparamagnetic iron oxide, calcium carbonate, doxorubicin and polyethylene glycol. The particles integrate magnetic properties with the capacity to retain drug molecules inside the pore matrix at neutral pH to facilitate drug delivery to tumor tissues. The MRI applicability and pH controlled drug release were examined in vitro together with in-depth material characterization. The in vivo biodistribution and compound safety were verified using A549 lung cancer bearing mice before proceeding to therapeutic experiments using CT26 cancer implanted mice. Loading doxorubicin into the porous nanoparticle negated the adverse side effects encountered after intravenous administration highlighting the particles’ excellent biocompatibility. Furthermore, the multifunctional nanovector induced 77% tumor reduction after intratumoral injection. The anti-tumor effect was comparable with that of free doxorubicin but with significantly alleviated unwanted effects. These results demonstrate that the developed porous silicon-based nanoparticles represent promising multifunctional drug delivery vectors for cancer monitoring and therapy.

Over the years, nanobiopolymers produced by living organisms such as nanostarch nanochitin, nanocellulose, and nanosilk, as well as microbial nanobiopolymers, have gained a wide scientific and engineering attraction mainly due to the benefits related to sustainability and biodegradability. Several mechanical, chemical, and biological methods have been employed for the fabrication of these nanobiopolymers and their respective composites. In this chapter, we present and discuss the different approaches that have been used for the fabrication of nanobiopolymers. Then, we summarize the methods commonly used for the preparation of nanobiopolymers in the later section of this chapter.

Visceral leishmaniasis is a vector-borne protozoan infection that is fatal if untreated. There is no vaccination against the disease, and the current chemotherapeutic agents are ineffective due to increased resistance and severe side effects. Buparvaquone is a potential drug against the leishmaniases, but it is highly hydrophobic resulting in poor bioavailability and low therapeutic efficacy. Herein, we loaded the drug into silicon nanoparticles produced from barley husk, which is an agricultural residue and widely available. The buparvaquone-loaded nanoparticles were several times more selective to kill the intracellular parasites being non-toxic to macrophages compared to the pure buparvaquone and other conventionally used anti-leishmanial agents. Furthermore, the in vivo results revealed that the intraperitoneally injected buparvaquone-loaded nanoparticles suppressed the parasite burden close to 100%. By contrast, pure buparvaquone suppressed the burden only by 50% with corresponding doses. As the conclusion, the biogenic silicon nanoparticles are promising carriers to significantly improve the therapeutic efficacy and selectivity of buparvaquone against resistant visceral leishmaniasis opening a new avenue for low-cost treatment against this neglected tropical disease threatening especially the poor people in developing nations., Author summary Visceral leishmaniasis is a neglected tropical disease caused by a protozoan parasite. It infects macrophage associated organs and invades the immune system. Currently, there is no vaccination against the disease and the conventional chemotherapeutic agents are ineffective due to the increased resistance and toxicity. In the present work, we utilized porous silicon nanoparticles as carriers for an anti-leishmanial drug (buparvaquone) to improve its therapeutic efficacy against visceral leishmaniasis (S1 Scheme). The nanoparticles were synthesized from an agricultural residue (barley husk), which is cheap and widely available. Due to the nano size of the nanoparticles, they internalized into the infected cells successfully. The efficacies of buparvaquone loaded in the nanoparticles were greatly improved in comparison with pure buparvaquone to evacuate the parasitic infection both in vitro and in vivo studies. Therefore, the biogenic silicon nanocarriers are promising candidates to be utilized as low-cost treatment regimen in leishmaniases therapy.

Complex experimental design is a common problem in the preparation of theranostic nanoparticles, resulting in poor reaction control, expensive production cost, and low experiment success rate. The present study aims to develop PEGylated bismuth (PEG-Bi) nanoparticles with a precisely controlled one-pot approach, which contains only methoxy[(poly(ethylene glycol)]trimethoxy-silane (PEG-silane) and bismuth oxide (BiO). A targeted pyrolysis of PEG-silane was achieved to realize its roles as both the reduction and PEGylation agents. The unwanted methoxy groups of PEG-silane were selectively pyrolyzed to form reductive agents, while the useful PEG-chain was fully preserved to enhance the biocompatibility of Bi nanoparticles. Moreover, BiO not only acted as the raw material of the Bi source but also presented a self-promotion in the production of Bi nanoparticles via catalyzing the pyrolysis of PEG-silane. The reaction mechanism was systematically validated with different methods such as nuclear magnetic resonance spectroscopy. The PEG-Bi nanoparticles showed better compatibility and photothermal conversion than those prepared by the complex multiple step approaches in literature studies. In addition, the PEG-Bi nanoparticles possessed prominent performance in X-ray computed tomography imaging and photothermal cancer therapy . The present study highlights the art of precise reaction control in the synthesis of PEGylated nanoparticles for biomedical applications.

Batteries are commonly considered one of the key technologies to reduce carbon dioxide emissions caused by the transport, power, and industry sectors. We need to remember that not only the production of energy needs to be realized sustainably, but also the technologies for energy storage need to follow the green guidelines to reduce the emission of greenhouse gases effectively. To reach the sustainability goals, we have to make batteries with the performances beyond their present capabilities concerning their lifetime, reliability, and safety. To be commercially viable, the technologies, materials, and chemicals utilized in batteries must support scalability that enables cost-effective large-scale production. As lithium-ion battery (LIB) is still the prevailing technology of the rechargeable batteries for the next ten years, the most practical approach to obtain batteries with better performance is to develop the chemistry and materials utilized in LIBs-especially in terms of safety and commercialization. To this end, silicon is the most promising candidate to obtain ultra-high performance on the anode side of the cell as silicon gives the highest theoretical capacity of the anode exceeding ten times the one of graphite. By balancing the other components in the cell, it is realistic to increase the overall capacity of the battery by 100%-200%. However, the exploitation of silicon in LIBs is anything else than a simple task due to the severe material-related challenges caused by lithiation/delithiation during battery cycling. The present review makes a comprehensive overview of the latest studies focusing on the utilization of nanosized silicon as the anode material in LIBs.

β-lactam–resistant Gram-negative bacteria with decrease in stiffness can be more efficiently penetrated by sharp nanowires., β-Lactam–resistant (BLR) Gram-negative bacteria that are difficult or impossible to treat are causing a global health threat. However, the development of effective nanoantibiotics is limited by the poor understanding of changes in the physical nature of BLR Gram-negative bacteria. Here, we systematically explored the nanomechanical properties of a range of Gram-negative bacteria (Salmonella, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae) with different degrees of β-lactam resistance. Our observations indicated that the BLR bacteria had cell stiffness values almost 10× lower than that of β-lactam–susceptible bacteria, caused by reduced peptidoglycan biosynthesis. With the aid of numerical modeling and experimental measurements, we demonstrated that these stiffness findings can be used to develop programmable, stiffness-mediated antimicrobial nanowires that mechanically penetrate the BLR bacterial cell envelope. We anticipate that these stiffness-related findings will aid in the discovery and development of novel treatment strategies for BLR Gram-negative bacterial infections.

The exploitation of various inorganic nanoparticles as drug carriers and therapeutics is becoming increasingly common. The first issue to be considered with regard to the nanomaterials being utilized in medicine centers on their safety. The functionality of nanocarriers in real-life environments explains the enthusiasm for their use. Several functionalities are typically added onto nanocarriers but the most crucial feature of those carriers intended to be administered intravenously is that they should possess a long residence time in blood circulation. The present review focusses on the mesoporous nanoparticles due to their great promise in nanomedicine and concentrates on their coatings because it is the outmost layer which dictates their first interactions with the surroundings and often determines their biofate.

Metal-assisted catalytic etching (MACE) involving Ag deposited on Si particles has been reported as a facile method for the production of Si nanowires (Si NWs). We show that the structure of Si particles subjected to MACE changes dramatically in response to changing the loading of the Ag catalyst. The use of acetic acid as a surfactant and controlled injection of AgNO3(aq) enhanced Ag deposition. The use of acetic acid and controlled injection of H2O2 not only facilitated optimization of the etching step but also allowed us to identify a previously unobserved etching regime that we denote as low-load MACE (LL-MACE). Material produced by LL-MACE exhibits dramatically different yield and structural characteristics as compared to conventionally produced material. We demonstrate the production of Si NWs as well as mesoporous Si nanoparticles from an inexpensive metallurgical-grade Si powder. High loading of Ag (HL-MACE) generates parallel etch track pores created by the correlated motion of Ag nanoparticles. The uniform size distribution (predominantly 70-100 nm) of the Ag nanoparticles is generated dynamically during etching. The walls of these etch track pores are cleaved readily by ultrasonic agitation to form Si NWs. Low loading of Ag (LL-MACE) creates 10-50 nm Ag nanoparticles that etch in an uncorrelated (randomly directed) fashion to generate a bimodal distribution of mesoporosity peaking at ∼4 and 13-21 nm. The use of a syringe pump to deliver the oxidant (H2O2) and Ag+ is essential for increased product uniformity and yield. Different process temperatures and grades of Si produced significantly different pore size distributions. These results facilitate the production of Si NWs and mesoporous nanoparticles with high yield, low cost, and controlled properties that are suitable for applications in, e.g., lithium-ion batteries, drug delivery, as well as biomedical imaging and contrast enhancement.

Scandium has several applications in advanced technology, but its wider utilization is restricted by the limited supply. Scandium exists in low concentration in ores and, therefore, the conventional extraction methods are difficult, uneconomical, and often hazardous to the environment. Adsorption is more sustainable method to extract scandium, because of low energy consumption and scalability. However, selectivity and stability of adsorbents are often inadequate. The present paper introduces a novel hybrid material as a robust adsorbent for efficient extraction of scandium. The material comprises of bisphosphonate molecules grafted on thermally carbonized surfaces of mesoporous silicon. The mesoporous framework was utilized to make the material water permeable to be used in a flow-through system, and the surface modifications made the material exceptionally stable even in harsh conditions. The material exhibited a remarkable selectivity towards scandium with a separation factor of 13, which is 3-fold higher compared with the commercial ion exchange resin Dowex 50WX8. Crucially, the hybrid material proved to be highly stable and reusable up to 50 adsorption/desorption cycles of scandium.

Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [111In]In-DOTA-PEG4-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [111In]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 &plusmn, 1.7% of the injected activity/g in blood at 15 min for [111In]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors.

When poor aqueous solubility of active pharmaceutical ingredients is encountered during a drug formulation process, the toolbox typically utilized contains pharmaceutical salts, co-crystals, solid dispersions, cyclodextrins, lipids, liposomes and nanocrystals etc. Especially in the pharmaceutical industry, the option which confers the greatest benefit with the lowest risk is usually chosen. Several factors affect the final decision, but new technologies should also be considered especially if they can address several issues at the same time. Mesoporous inorganic systems are emerging technologies which can be utilized for improving the dissolution of poorly soluble drugs. The number of the scientific papers in this field is steadily increasing and the focus of the studies is moving away from in vitro to in vivo experiments with the first human trial already completed. Meanwhile, several start-up companies focusing on mesoporous carriers have been established. Therefore, it is conceivable that the first commercial products will find their way to pharmacies during the next 5-10 years. The present review surveys recent progress in research on mesoporous materials as carriers of poorly soluble drugs. We will concentrate on the research published since our previous review published in 2012 [10.1016/j.ijpharm.2012.09.008] up to the present day.

Anthropogenic activities such as mining and ore beneficiation generate large amounts of uranium-contaminated wastewater. The metal is radioactive and toxic; therefore, it needs to be removed to protect the environment and human health. Adsorption is a viable method to remove uranium from wastewater because of the low energy consumption and ability to remove even low concentrations of uranium. However, most adsorbents are not effective to selectively adsorb uranium and their stability is typically degraded in repeated adsorption/desorption cycles. Herein, we employed a novel nanostructured adsorbent to selectively remove uranium from a tailing obtained from processing of real ore sample by Knelson concentration method. The adsorbent consisted of bisphosphonate ligands grafted on highly stable carbonized surfaces of mesoporous silicon. The porous structure of the adsorbent enhanced its permeability allowing it to be used in a column setup where metal solutions were flown through the adsorbent. The adsorbent was capable of repeatedly adsorbing and desorbing uranium without significant reduction in the performance. Importantly, the adsorbent showed essentially higher selectivity towards uranium than towards other less harmful metal ions, and the material could be regenerated with an acid. Desorption was carried out with sulfuric acid resulting in 15-fold enrichment of uranium compared to the initial solution, while other metals did not concentrate efficiently. The adsorbent was capable of selectively capturing uranium from a solution with various other metals and the adsorbed uranium was rapidly desorbed and quantified with a reasonable purity, indicating the adsorbent as a potential candidate for industrial applications.